IT1199374B
(it)
*
|
1984-05-15 |
1988-12-30 |
Alfa Farmaceutici Spa |
Processo per la preparazione di pirido-imidazo-rifamicine
|
IT1264494B1
(it)
*
|
1993-03-23 |
1996-09-24 |
Alfa Wassermann Spa |
Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
US5981522A
(en)
*
|
1995-09-01 |
1999-11-09 |
Kaneka Corporation |
Treatment of disease caused by infection of Helicobacter
|
DE69829905T2
(de)
*
|
1997-02-28 |
2006-03-09 |
Kaneka Corp. |
Heilmittel für durch Helicobacter verursachte Krankheit
|
WO2003045319A2
(en)
*
|
2001-11-21 |
2003-06-05 |
Activbiotics, Inc. |
Targeted therapeutics and uses thereof
|
AU2002364162A1
(en)
*
|
2001-12-13 |
2003-06-30 |
Activbiotics, Inc. |
Sulfhydryl rifamycins and uses thereof
|
EP1560566B1
(en)
*
|
2002-11-05 |
2012-04-11 |
Fadim S.r.l. |
Controlled and continued delivery of rifaximin
|
US7820652B2
(en)
*
|
2003-09-24 |
2010-10-26 |
Activbiotics Pharma, Llc |
Regimen for the administration of rifamycin-class antibiotics
|
US20080262024A1
(en)
*
|
2003-11-07 |
2008-10-23 |
Giuseppe Claudio Viscomi |
Rifaximin compositions and method of use
|
US7906542B2
(en)
*
|
2004-11-04 |
2011-03-15 |
Alfa Wassermann, S.P.A. |
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
|
ITMI20032144A1
(it)
|
2003-11-07 |
2005-05-08 |
Alfa Wassermann Spa |
Forme polimorfe di rifaximina, processi per ottenerle e
|
US7923553B2
(en)
*
|
2003-11-07 |
2011-04-12 |
Alfa Wassermann, S.P.A. |
Processes for the production of polymorphic forms of rifaximin
|
US7902206B2
(en)
*
|
2003-11-07 |
2011-03-08 |
Alfa Wassermann, S.P.A. |
Polymorphic forms α, β and γ of rifaximin
|
US7256187B2
(en)
*
|
2004-03-10 |
2007-08-14 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
|
US7265107B2
(en)
*
|
2004-03-10 |
2007-09-04 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
|
US7202246B2
(en)
*
|
2004-06-09 |
2007-04-10 |
Cumbre Pharmaceuticals Inc. |
Spiro-rifamycin derivatives targeting RNA polymerase
|
US20060210492A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Use of rifaximin for treatment and prevention of periodontal conditions
|
US20060210483A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
|
US8003118B2
(en)
*
|
2005-03-02 |
2011-08-23 |
Kodsi Robert E |
Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
|
DK1698630T3
(da)
*
|
2005-03-03 |
2014-12-08 |
Alfa Wassermann Spa |
Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater
|
ITBO20050123A1
(it)
*
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
JP5368092B2
(ja)
|
2005-08-11 |
2013-12-18 |
ターガンタ セラピュティクス,インコーポレイティド |
ホスホン化リファマイシン類および骨と関節感染の予防と治療のためのその投与法
|
EP1996710B1
(en)
|
2006-03-09 |
2019-08-14 |
Salix Pharmaceuticals, Inc. |
Rifaximin anti-rectal dysfunction preparation
|
KR20150132214A
(ko)
|
2006-08-02 |
2015-11-25 |
샐릭스 파마슈티컬스 인코포레이티드 |
방사선 직장s상결장염의 치료를 위한 조성물 및 방법
|
ITMI20061692A1
(it)
|
2006-09-05 |
2008-03-06 |
Alfa Wassermann Spa |
Uso di polioli per ottenere forme polimorfe stabili di rifaximina
|
WO2008035109A1
(en)
*
|
2006-09-22 |
2008-03-27 |
Cipla Limited |
Rifaximin
|
US20080161337A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Chronic Prostatitis
|
US20080159987A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Restless Legs Syndrome
|
ITMI20071241A1
(it)
*
|
2007-06-20 |
2008-12-21 |
Solmag S P A |
Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
|
EP3714878B1
(en)
|
2007-07-06 |
2022-01-19 |
Lupin Limited |
Pharmaceutical compositions of rifaximin
|
AU2008273699A1
(en)
|
2007-07-06 |
2009-01-15 |
Lupin Limited |
Pharmaceutical compositions of rifaximin
|
US7709634B2
(en)
*
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
US8486956B2
(en)
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
BRPI0908864A2
(pt)
*
|
2008-02-25 |
2018-09-18 |
Salix Pharmaceuticals Ltd |
formas da rifaximina e usos das mesmas
|
US11779571B2
(en)
|
2008-02-26 |
2023-10-10 |
Salix Pharmaceuticals, Inc. |
Methods for treating irritable bowel syndrome (IBS)
|
PL2252148T3
(pl)
|
2008-02-26 |
2019-09-30 |
Salix Pharmaceuticals, Ltd. |
Sposoby leczenia zespołu jelita drażliwego
|
ES2509892T3
(es)
|
2008-05-07 |
2014-10-20 |
Salix Pharmaceuticals, Ltd. |
Administración de un agente para limpieza del intestino y antibiótico para el tratamiento de enfermedad intestinal
|
EP2324041A4
(en)
|
2008-08-13 |
2012-06-13 |
Targanta Therapeutics Corp |
PHOSPHONIZED RIFAMYCINS AND ITS APPLICATION FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS
|
CA2736285C
(en)
|
2008-09-26 |
2016-08-23 |
Aska Pharmaceutical Co., Ltd. |
Agent for preventing and/or treating functional gastrointestinal disorder
|
FI3628319T3
(fi)
|
2008-10-02 |
2024-03-12 |
Salix Pharmaceuticals Ltd |
Hepaattisen enkefalopatian hoito rifaksimiinilla
|
US8916193B2
(en)
|
2008-12-10 |
2014-12-23 |
Cipla Limited |
Rifaximin complexes
|
IT1397617B1
(it)
*
|
2009-04-20 |
2013-01-18 |
Alfa Wassermann Spa |
Nuovi derivati della rifamicina
|
MX2011012829A
(es)
|
2009-06-02 |
2012-02-28 |
Salix Pharmaceuticals Ltd |
Metodos para tratar encefalopatia hepatica.
|
NZ598671A
(en)
|
2009-09-13 |
2014-02-28 |
Salix Pharmaceuticals Ltd |
Methods for treating irritable bowel syndrome (ibs)
|
KR20140015140A
(ko)
|
2009-10-27 |
2014-02-06 |
루핀 리미티드 |
리팍시민의 고형 분산물
|
CN102724960A
(zh)
|
2009-11-23 |
2012-10-10 |
希普拉有限公司 |
局部泡沫组合物
|
EP2401282B2
(en)
|
2009-12-28 |
2017-01-04 |
Silvio Massimo Lavagna |
Method for the production of amorphous rifaximin
|
EP3650022A1
(en)
|
2010-02-18 |
2020-05-13 |
Salix Pharmaceuticals, Ltd. |
Methods for treating rifampin resistant clostridium difficilis infections
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
JP6092629B2
(ja)
|
2010-03-10 |
2017-03-08 |
ルピン・リミテッドLupin Limited |
リファキシミン使用準備済懸濁液
|
US20120077835A1
(en)
|
2010-07-12 |
2012-03-29 |
Salix Pharmaceuticals, Ltd. |
Formulations of rifaximin and uses thereof
|
US8759513B2
(en)
|
2010-09-13 |
2014-06-24 |
Sequent Scientific Limited |
Polymorphic form of rifaximin and process for its preparation
|
PT2672970T
(pt)
|
2011-02-11 |
2018-10-11 |
Salix Pharmaceuticals Ltd |
Formas de rifaximina e suas utilizações
|
WO2012150561A1
(en)
|
2011-05-02 |
2012-11-08 |
Ranbaxy Laboratories Limited |
Rifaximin dimethylformamide solvate
|
ITMI20110890A1
(it)
|
2011-05-19 |
2012-11-20 |
A M S A Anonima Materie Sint & Affini S P A |
Polimorfo di rifaximina e processo per la sua preparazione
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
RU2496475C2
(ru)
|
2011-10-26 |
2013-10-27 |
Александр Васильевич Иващенко |
Фармацевтическая композиция и набор для лечения бактериальных инфекций
|
WO2013067394A1
(en)
|
2011-11-02 |
2013-05-10 |
Salix Pharmaceuticals, Ltd |
Methods for treating irritable bowel syndrome (ibs) and infections
|
CA2861104A1
(en)
*
|
2012-01-25 |
2013-08-01 |
Salix Pharmaceuticals, Ltd. |
Rifaximin derivative and uses thereof
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
WO2014091432A1
(en)
|
2012-12-12 |
2014-06-19 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions of rifaximin
|
CA2897758A1
(en)
|
2013-03-15 |
2014-09-18 |
Alfa Wassermann S.P.A. |
Rifaximin for use in the treating of vaginal infections
|
US20160047819A1
(en)
|
2013-03-15 |
2016-02-18 |
Alfa Wassermann S.P.A. |
Method for diagnosing vaginal infections
|
PL2983647T3
(pl)
|
2013-04-12 |
2021-01-25 |
Alfasigma S.P.A. |
Podawanie nlpz oraz związane z tym składniki, sposoby i układy
|
US9018225B1
(en)
|
2013-07-26 |
2015-04-28 |
Novel Laboratories |
Rifaximin crystalline forms and methods of preparation thereof
|
ES2621557T3
(es)
|
2014-03-31 |
2017-07-04 |
Euticals S.P.A. |
Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
|
EP3140313B1
(en)
|
2014-05-04 |
2020-02-26 |
Salix Pharmaceuticals, Inc. |
Ibs microbiota and uses thereof
|
NZ723571A
(en)
|
2014-05-12 |
2020-02-28 |
Alfasigma Spa |
New solvated crystal form of rifaximin, production, compositions and uses thereof
|
EP2982764A1
(en)
|
2014-08-05 |
2016-02-10 |
ALFA WASSERMANN S.p.A. |
Identification of vaginal bacteria
|
US9988398B2
(en)
|
2016-06-07 |
2018-06-05 |
Cadila Healthcare Limited |
Crystalline form of rifaximin and process for its preparation
|
JP7027412B2
(ja)
|
2016-09-30 |
2022-03-01 |
サリックス ファーマスーティカルズ,インコーポレーテッド |
リファキシミンの固体分散体の形態
|
IT201700091912A1
(it)
*
|
2017-08-08 |
2019-02-08 |
Biofer Spa |
Nuove pirido-imidazo rifamicine
|
PL3645539T3
(pl)
*
|
2017-06-26 |
2021-10-25 |
Biofer S.P.A. |
Pochodne pirydoimidazoryfamycyny jako środek przeciwbakteryjny
|